Drawing for COEVNIXA

USPTO serial 99617030

COEVNIXA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with COEVNIXA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Colin Rasmussen

Colin Rasmussen ASCUS IP LAW, PC3027 Michelle DriveColton, CA 92324United States

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplements for pets in the nature of a powdered drink mix; Dietary pet supplements in the form of pet treats; Medicated supplements for foodstuffs for animals; Sore skin ointment for pets; Pharmaceutical preparations for the treatment of worms in pets; Protein supplements for animals; Nutritional supplements for pets, livestock; Feed supplements for pets, livestock; Vitamins and dietary food supplements for animals; Dietary supplements for petsACTIVEJan 5, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 28, 2026MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Jan 28, 2026ABN1ABANDONMENT - EXPRESS MAILED—
Jan 27, 2026EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jan 27, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 27, 2026TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Jan 27, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 27, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 27, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance